CD95/Fas signaling in T lymphocytes induces the cell cycle control protein p21(cip-1/WAF-1), which promotes apoptosis

Journal of Immunology

Volumn 164, Issue 8, 2000, Pages 4032-4036

  Hingorani, Ravi ^a   Bi, BaoYuan ^b   Dao, Tao ^c   Bae, Youngmee ^d   Matsuzawa, Akio ^e   Crispe, I Nicholas ^b  

^a BD Technologies   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Korea National University   (South Korea)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; CELL DNA; FAS ANTIGEN; PROTEIN FAS ASSOCIATED DEATH DOMAIN; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME INHIBITION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0034655164     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.8.4032     Document Type: Article

References (34)

1. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenk, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817.
2. Srinivasula, S. M., M. Ahmad, T. Fernandez-Alnemri, G. Litwack, and E. S. Alnemri. 1996. Molecular ordering of the Fas-apoptotic pathway: the Fas/ APO-1 protease Mch-5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA 93:14486.
3. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, co-stimulation and death. Cell 76:959.
4. Alderson, M. R., R. L. Armitage, E. Marakovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231.
5. Biacone, L., A. De Martino, V. Orlandi, P. G. Conaldi, A. Toniolo, and G. Camussi. 1997. Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J. Exp. Med. 186:147.
6. Wilson, D. J., K. A. Fortner, D. H. Lynch, R. R. Mattingly, I. G. Macara, and J. A. Posada. 1996. JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur. J. Immunol. 26:989.
7. Toyoshima, F., T. Moriguchi, and E. Nishida. 1997. Fas induced cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. J. Cell Biol. 139:1005.
8. Juo, P., C. J. Cuo, S. E. Reynolds, R. F. Konz, J. Raingeaud, R. J. Davis, H.-P Biemann, and J. Blenis. 1997. Fas activation of the p38 mitogen-activated protein kinase signaling pathway requires ICE/CED3 family proteases. Mol. Cell. Biol. 17:24.
9. Goillot, E., J. Raingeaud, A. Ranger, R. I. Tepper, R. J. Davis, E. Harlow, and I. Sanchez. 1997. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sci. USA 94:3302.
10. Dao, T., J. W. Huleatt, R. Hingorani, and I. N. Crispe. 1997. Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle. J. Immunol. 159:4261.
11. Pumiglia, K. M., and S. J. Decker. Cell cycle arrest mediated by the MEK/ mitogen-activated protein kinase pathway. 1997. Proc. Natl. Acad. Sci. USA 94: 448.
12. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701.
13. El-Diery, W. S., T. Tokino, V. E. Valculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, E. Mercer, K. W. Kinzler, and B. Vogelsetein. 1993. WAF-1, a potential mediator of p53 tumor suppression. Cell 75:817.
14. Hughes, D. P. M., and I. N. Crispe. 1995. A soluble inhibitory isoform of murine Fas generated by alternative splicing. J. Exp. Med. 182:1395.
15. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and F. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271.
16. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature 391:43.
17. Woo, R. A., K. G. McLure, S. P. Lees-Miller, D. E. Rancourt, and P. W. K. Lee. 1998. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature 394:700.
18. Agarwal, M. L., W. R. Taylor, M. V. Chernov, O. B. Chernova, and G. R. Stark. 1998. The p53 network. J. Biol. Chem. 273:1.
19. Greidinger, E. L., D. K. Miller, T. T. Yamin, L. Casciola-Rosen, and A. Rosen. 1996. Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Lett. 390:299.
20. Casciola-Rosen, L., D. W. Nicholson, T. Chong, K. R. Rowan, N. A. Thornberry, D. K. Miller, and A. Rosen. 1996. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183:1957.
21. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
22. Macleod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage. Genes Dev. 9:935.
23. Itoh, N., and S. Nagata. 1993. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J. Biol. Chem. 268:10932.
24. CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis. J. Cell. Biochem. 64:434.
25. Miyashita T, and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293.
26. Attardi, L.D., S. W. Lowe, J. Brugarolas, and T. Jacks. 1996. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15:3693.
27. Sekiguchi T, and T. Hunter. 1998. Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells. Oncogene 16:369.
28. 1 cyclin-dependent kinases. Cell 73:805.
29. Sherr, C. J. 1994. The ins and outs of RB: coupling gene expression to the cell cycle clock. Trends Cell Biol. 4:15.
30. Jooss, K., E. W. Lam, A. Bybee, R. Girling, R. Muller, and N. B. La Thangue. 1995. Proto-oncogenic properties of the DP family of proteins. Oncogene 10: 1529.
31. Kowalik, T. F., J. DeGregori, G. Leone, L. Jakoi, and J. R. Nevins. 1998. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ. 9:113.
32. Nip, J., D. K. Strom, B. E. Fee, G. Zambetti, J. L. Cleveland, and S. W. Hiebert. 1997. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol. Cell. Biol. 17:1049.
33. Phillips, A. C., S. Bates, K. M. Ryan, K. Helin, and K. H. Vousden. 1997. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11:1853.
34. Field, S. J., F. Y. Tsai, F. Kuo, A. M. Zubiaga, W. G. Kaelin, Jr., D. M. Livingston, and M. E. Greenberg. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549.